The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global peripheral artery disease market reached a value of US$ 4.11 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 5.91 Billion by 2027, exhibiting a CAGR of 6.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).
At present, there is a rise in the geriatric population across the globe. This, along with changing lifestyles of individuals, increasing adoption of unhealthy dietary patterns, alcoholism, and obesity on account of lack of physical activities, represents one of the key factors driving the market. Moreover, there is an increase in the adoption of minimally invasive surgeries (MIS) due to less postoperative pain, fewer operative and major postoperative complications, shortened hospital stay, faster recovery times, and less stress on the immune system. This, coupled with the expanding healthcare industry, is propelling the growth of the market. In addition, governments of several countries are undertaking initiatives to spread awareness about the benefits of PAD devices, which is positively influencing the market. Besides this, the rising prevalence of cardiac diseases among individuals around the world is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on mergers and acquisitions (M&A) to strengthen PAD treatment capabilities. These players are also focusing on various developmental strategies, which are projected to bolster their overall profitability.
IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral artery disease market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type and end user.
Breakup by Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Pregnancy Detection Kits Market by Product (Home Pregnancy Tests (HPT), Digital Devices, and Others), Test Type (Urine Test for HCG, Blood Test for HCG, and Others), End User (Household, Gynecology Clinics, Hospitals), and Region 2023-2028
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at